Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centre Suisse de Recherches Scientifique en Côte d'Ivoire | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to learn if a conditional social transfer works to improve rates of complementary breastfeeding. It will also learn about the impacts of social transfers on maternal and child health and development. The main questions it aims to answer are:
Researchers will compare a conditional social transfer to a control group that only receives education about breastfeeding recommendations to see if a conditional social transfers works to increase complementary breastfeeding.
Participants will:
Receive a pamphlet explaining the current recommendations of breastfeeding Receive instructions that if they meet the recommendation to breastfeed until 24-months postpartum they receive a social transfer or receive no additional information Complete home visits at 12- and 24-months postpartum Complete detailed questionnaire
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Social Transfer | Experimental | A social transfer is provided at the 24-month visit, conditional on the mother still breastfeeding at the time of the visit. They also receive education about current breastfeeding recommendations. |
|
| Control | No Intervention | No intervention is provided besides education on current breastfeeding recommendations. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Social Transfer | Other | A social transfer will be given conditioned upon breastfeeding at 24-months postpartum. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of Complementary Breastfeeding | Prevalence of complementary breastfeeding at 24 months postpartum. | from 12 to 24 months postpartum |
| Complementary Breastfeeding Duration | Duration of complementary breastfeeding in weeks. | from 12 to 24 months postpartum |
| Measure | Description | Time Frame |
|---|---|---|
| Weight-for-Age z-score | Infants will be weighed in kilograms by a mobile weighing scale. Measurements will be analyzed as age standardized z-scores. | 12 months; 24 months |
| Child Health Outcomes |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Taabo Health and Demographic Surveillance | Taabo | Côte d’Ivoire |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We will assess the child's health outcomes by using a questionnaire administered to the caregiver. The questionnaire will ask a range of yes or no questions about child diarrhea, respiratory illness, fever, and child antibiotic use.
| 12 months; 24 months |
| Percent weight loss | Percent weight loss will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Percent weight loss will be calculated as ((current weight - pregnancy weight) / pregnancy weight) × 100. | 12 months; 24 months; |
| Mother and Child Hemoglobin Levels | We will assess the mother and child anemia levels. The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Iron levels will be analyzed as a continuous outcome. | 12 months; 24 months |
| Maternal Depression | Maternal postpartum depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9); categorized as a binary: no depression (score <10) or depression present (score ≥10). | 12 months; 24 months |
| Height-for-age z-score | Height will be measured in centimeters by using a Height Measuring Device, stadiometer, 20-205cm. All measurements will be analyzed as age standardized z-scores | 12 months; 24 months |
| Mid-upper arm circumference (MUAC) | Infants will be measured for mid-upper arm circumference (MUAC) using non-stretchable measuring tape. All measurements will be analyzed as age standardized z-scores. | 12 months; 24 months |
| Mother and Child Anemia | The HemoCue Hb 301 will be used to give an instant measurement of the Haemoglobin (Hb) level of the patient. Capillary blood will be collected through a finger prick. Blood samples drawn for the haemoglobin assessment will be discarded after the test. Hemoglobin levels (gm/dL) will be used to categorize mothers and children into a binary variable: anemic or not anemic. | 12 months; 24 months |
| Maternal weight change | Weight weight change will use body weight (kg) and pregnancy weight of the mother controlling for time of measurement. Maternal weight change will be calculated as the difference between postpartum weight and pregnancy weight. Because pregnancy weight varies by gestational age, analyses will control for gestational age at pregnancy weight measurement and time postpartum at outcome measurement. Categorized as: no weight loss (0 kg); moderate weight loss (<0 to >-5 kg); high weight loss (≥-5 kg); moderate weight gain (>0 to <5 kg); high weight gain (≥5 kg). | 12 months; 24 months; |
| Change in systolic and diastolic blood pressure (mmHg) | Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be categorized as low, normal, or high according to standard clinical thresholds. | 12 months; 24 months; |
| Change in systolic and diastolic blood pressure (mmHg) | Change in systolic and diastolic blood pressure (mmHg) from baseline of the mothers will be analyzed as a continuous measure. | 12 months; 24 months; |
| Caregiver Reported Early Development Instruments (CREDI) cognitive z-score | The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure. | 12 months; 24 months |
| CREDI language z-score | The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure. | 12 months; 24 months |
| CREDI motor z-score | The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure. | 12 months; 24 months |
| CREDI social-emotional z-score | The CREDI long-form will be administered. Raw item data will be converted to norm-referenced z-scores using the CREDI scoring procedure. | 12 months; 24 months |
| Maternal Anxiety | Maternal postpartum anziety will be assessed using the the GAD-7 (Generalized Anxiety Disorder-7); a seven-item self-report questionnaire designed to measure the severity of anxiety; categorized as: Minimal Anxiety: score 0-4; Mild Anxiety: score 5-9; Moderate Anxiety: score 10-14; Severe Anxiety: score 15-21 | 12 months; 24 months |
| ID | Term |
|---|---|
| D001942 | Breast Feeding |
| D003141 | Communicable Diseases |
| D000740 | Anemia |
| D015431 | Weight Loss |
| D000092862 | Psychological Well-Being |
| D003967 | Diarrhea |
| D003371 | Cough |
| D004485 | Eczema |
| D006967 | Hypersensitivity |
| ID | Term |
|---|---|
| D005247 | Feeding Behavior |
| D001519 | Behavior |
| D007239 | Infections |
| D020969 | Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D001836 | Body Weight Changes |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D010549 | Personal Satisfaction |
| D012817 | Signs and Symptoms, Digestive |
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D003872 | Dermatitis |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D017443 | Skin Diseases, Eczematous |
| D007154 | Immune System Diseases |
Not provided
Not provided